![]() Innovative therapies, innovative infrastructure “In that regard, the kind of close collaboration you see between basic, translational, population and clinical scientists across campuses - and across the age span - is going to make a tremendous difference.” “To really understand cancer and other disorders of humankind, we have to think about developmental biology,” said Alan Wayne, M.D., director of Children’s Hospital Los Angeles Cancer & Blood Disease Institute and associate director for pediatric oncology at USC Norris Comprehensive Cancer Center. So fully integrating oncology research between the two institutions has been a priority. ![]() Like many other diseases, cancer is understood to find its roots early along in development - as far back as the womb. The USC Norris $34 million Cancer Center Support Grant from the NCI supports cutting-edge cancer research and collaborations that span USC and CHLA. USC Norris Comprehensive Cancer Center stands among the original eight such centers to receive the National Cancer Institute’s highest designation in 1971, and remains an innovative leader in the cancer field. Several initiatives backed by federal grants exemplify a partnership with impact exceeding the sum of its parts. As such, both institutions emphasize studies to address the health challenges of communities that are underserved and experience disparities in outcomes. Faculty from the Keck School of Medicine staff Los Angeles County + USC Medical Center, the largest single provider of health care in the county. CHLA is a safety net pediatric hospital, with 70% of patients on subsidized healthcare or lacking insurance. Together, the two research and academic powerhouses - independent of each other - make a bigger difference than either could make alone.īoth institutions play vital roles serving the diverse L.A. The faculty at CHLA, which ranks among the nation’s top 10 children’s hospitals, all hold appointments at the Keck School of Medicine, which is home to eight departments that rank top 10 in NIH funding in their fields. “It’s a natural bridge, for instance, from CHLA’s disease-focused basic and translational research to the Keck School of Medicine’s fundamental work on understanding disease processes.” Keck Provost Professor in Neurogenetics at USC. “When one investigator at one site has a burning question, they can cross over to seek expertise in how to approach that question,” said Pat Levitt, PhD, chief scientific officer, vice president and director of the Saban Research Institute and Simms/Mann Chair in Developmental Neurogenetics at CHLA, who is also W.M. Connecting CHLA and the Keck School of Medicine opens the way for researchers to find complementary resources and interdisciplinary teammates across both. The tightly knit alliance benefits health for people of all ages. The institutions share a commitment to conducting leading-edge biomedical investigations, improving health outcomes for underserved populations and speeding new advances from the proverbial lab bench to the patient’s bedside. communities and preventing obesity in Latino youth. These include major efforts that tackle some of the most challenging problems in human health - battling cancer, manufacturing the latest cell therapies to fight incurable disease, boosting COVID-19 vaccination rates in underrepresented L.A. Projects foster therapeutic advances, patient care innovation and community wellness. medical mainstays are united by nearly 60 research programs supported by external grants, the lion’s share from the National Institutes of Health and other federal funders. For the Keck School of Medicine of USC and Children’s Hospital Los Angeles, there’s no shortage of common ground.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |